Refund to the Federal Government $241,533 (Federal share) for claims for top-20 multiple-source physician-administered drugs that were ineligible for Federal reimbursement
Questioned Costs
$241533
Funds for Better Use
$0
Recommendation Status
Open
Source UUID
22-A-07-080-22-A-07-08002
Report
Recommendation Number
22-A-07-08002
Significant Recommendation
No